Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew G Rees

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Molecular Cancer Therapeutics|November 21, 2023
Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome BiogenesisPrahalathan Pichavaram, Carolyn M Jablonowski, Jie Fang, et al.
Molecular Cancer Therapeutics|December 23, 2024
Pan-KRAS Inhibitors BI-2493 and BI-2865 Display Potent Antitumor Activity in Tumors with KRAS Wild-type Allele AmplificationAntonio Tedeschi, Fiorella Schischlik, Francesca Rocchetti, et al.
Nature Genetics|September 25, 2023
Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalitiesLiang Chang, Nancy Y Jung, Adel Atari, et al.
Cell Reports|May 1, 2024
Genetic dependencies associated with transcription factor activities in human cancer cell linesVenu Thatikonda, Verena Supper, Johannes Wachter, et al.
Science (New York, N.Y.)|July 21, 2022
Massively parallel pooled screening reveals genomic determinants of nanoparticle deliveryNatalie Boehnke, Joelle P Straehla, Hannah C Safford, et al.
Nature Chemical Biology|March 25, 2022
Systematic identification of biomarker-driven drug combinations to overcome resistanceMatthew G Rees, Lisa Brenan, Mariana do Carmo, et al.
Nature Chemical Biology|October 26, 2023
Targeting ROS production through inhibition of NADPH oxidasesJoana Reis, Christoph Gorgulla, Marta Massari, et al.
Cancer Research|March 15, 2024
A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH MedulloblastomaGrace H Hwang, Maria F Pazyra-Murphy, Hyuk-Soo Seo, et al.
Journal of the American Chemical Society|May 30, 2024
Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain CancersEric D Huseman, Anna Lo, Olga Fedorova, et al.
Journal of Medicinal Chemistry|March 22, 2023
Structure-Based Design of Y-Shaped Covalent TEAD InhibitorsWenchao Lu, Mengyang Fan, Wenzhi Ji, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Molecular Cancer Therapeutics|November 21, 2023
Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome BiogenesisPrahalathan Pichavaram, Carolyn M Jablonowski, Jie Fang, et al.
Molecular Cancer Therapeutics|December 23, 2024
Pan-KRAS Inhibitors BI-2493 and BI-2865 Display Potent Antitumor Activity in Tumors with KRAS Wild-type Allele AmplificationAntonio Tedeschi, Fiorella Schischlik, Francesca Rocchetti, et al.
Nature Genetics|September 25, 2023
Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalitiesLiang Chang, Nancy Y Jung, Adel Atari, et al.
Cell Reports|May 1, 2024
Genetic dependencies associated with transcription factor activities in human cancer cell linesVenu Thatikonda, Verena Supper, Johannes Wachter, et al.
Science (New York, N.Y.)|July 21, 2022
Massively parallel pooled screening reveals genomic determinants of nanoparticle deliveryNatalie Boehnke, Joelle P Straehla, Hannah C Safford, et al.
Nature Chemical Biology|March 25, 2022
Systematic identification of biomarker-driven drug combinations to overcome resistanceMatthew G Rees, Lisa Brenan, Mariana do Carmo, et al.
Nature Chemical Biology|October 26, 2023
Targeting ROS production through inhibition of NADPH oxidasesJoana Reis, Christoph Gorgulla, Marta Massari, et al.
Cancer Research|March 15, 2024
A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH MedulloblastomaGrace H Hwang, Maria F Pazyra-Murphy, Hyuk-Soo Seo, et al.
Journal of the American Chemical Society|May 30, 2024
Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain CancersEric D Huseman, Anna Lo, Olga Fedorova, et al.
Journal of Medicinal Chemistry|March 22, 2023
Structure-Based Design of Y-Shaped Covalent TEAD InhibitorsWenchao Lu, Mengyang Fan, Wenzhi Ji, et al.
Pageof 8